发明公开
EP2968277A1 ALPHA-2 ADRENERGIC AGONIST FOR TREATING INTRAOCULAR PRESSURE AND OCULAR DISEASES THROUGH INTRAVITREAL AND INTRACAMERAL ROUTES
审中-公开
用于治疗眼内压和眼病通过玻璃体内和给药前房内α-2-肾上腺素能受体激动剂
- 专利标题： ALPHA-2 ADRENERGIC AGONIST FOR TREATING INTRAOCULAR PRESSURE AND OCULAR DISEASES THROUGH INTRAVITREAL AND INTRACAMERAL ROUTES
- 专利标题（中）： 用于治疗眼内压和眼病通过玻璃体内和给药前房内α-2-肾上腺素能受体激动剂
-
申请号： EP14728695.9申请日： 2014-03-12
-
公开(公告)号： EP2968277A1公开(公告)日： 2016-01-20
- 发明人: DONELLO, John E. , GIL, Daniel W. , DIBAS, Mohammed I.
- 申请人： ALLERGAN, INC.
- 申请人地址： 2525 Dupont Drive Irvine, CA 92612 US
- 专利权人： ALLERGAN, INC.
- 当前专利权人： ALLERGAN, INC.
- 当前专利权人地址： 2525 Dupont Drive Irvine, CA 92612 US
- 代理机构： Hoffmann Eitle
- 优先权： US201361785757P 20130314
- 国际公布： WO2014159576 20141002
- 主分类号： A61K31/4184
- IPC分类号： A61K31/4184
摘要：
The present invention provides a method of lowering intraocular pressure which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin-2-ylamino)benzimidazole, or a salt thereof to the affected eye of a patient, as a single dose, wherein the affected eye has an intraocular pressure less than the baseline.
信息查询
IPC分类:
